{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:02:46Z","timestamp":1789459366607,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1006\/bbrc.2000.4130","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T14:49:19Z","timestamp":1032187759000},"page":"334-339","source":"Crossref","is-referenced-by-count":171,"title":["Effects of Immunosuppressants on Receptor Activator of NF-\u03baB Ligand and Osteoprotegerin Production by Human Osteoblastic and Coronary Artery Smooth Muscle Cells"],"prefix":"10.1006","volume":"280","author":[{"given":"Lorenz C.","family":"Hofbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxiang","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.Lawrence","family":"Riggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin R.","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Spelsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/bbrc.2000.4130_RF1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199408113310610","article-title":"New issues in therapy after renal transplantation","volume":"331","author":"Luke","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/bbrc.2000.4130_RF2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.5650110102","article-title":"Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton","volume":"11","author":"Epstein","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/bbrc.2000.4130_RF3","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2165\/00003495-199754060-00009","article-title":"Tacrolimus","volume":"54","author":"Spencer","year":"1997","journal-title":"Drugs"},{"key":"10.1006\/bbrc.2000.4130_RF4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/00007890-199404270-00016","article-title":"The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK-506 on bone mineral metabolism in vivo","volume":"57","author":"Cvetkovic","year":"1994","journal-title":"Transplantation"},{"key":"10.1006\/bbrc.2000.4130_RF5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jbmr.5650100513","article-title":"Rapamycin: A bone sparing immunosuppressant?","volume":"10","author":"Romero","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/bbrc.2000.4130_RF6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF01352014","article-title":"Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats","volume":"53","author":"Joffe","year":"1993","journal-title":"Calcif. Tissue Int."},{"key":"10.1006\/bbrc.2000.4130_RF7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0039-6060(98)70168-0","article-title":"Cyclosporine A, but not FK506, selectively induces renal and coronary artery smooth muscle contraction","volume":"123","author":"Epstein","year":"1998","journal-title":"Surgery"},{"key":"10.1006\/bbrc.2000.4130_RF8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00007890-199510150-00020","article-title":"Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts","volume":"60","author":"Schmid","year":"1995","journal-title":"Transplantation"},{"key":"10.1006\/bbrc.2000.4130_RF9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jbmr.5650040314","article-title":"Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption","volume":"4","author":"Movsowitz","year":"1989","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/bbrc.2000.4130_RF10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02556208","article-title":"Cyclosporine friend or foe?","volume":"49","author":"Epstein","year":"1991","journal-title":"Calcif. Tissue Int."},{"key":"10.1006\/bbrc.2000.4130_RF11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0041-1345(98)01739-4","article-title":"Cyclosporine A stimulates proliferation of vascular smooth muscle cells and enhances monocyte adhesion to vascular smooth muscle cells","volume":"31","author":"Hu","year":"1999","journal-title":"Transplant. Proc."},{"key":"10.1006\/bbrc.2000.4130_RF12","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin (OPG) ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1006\/bbrc.2000.4130_RF13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","article-title":"A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function","volume":"390","author":"Anderson","year":"1997","journal-title":"Nature"},{"key":"10.1006\/bbrc.2000.4130_RF14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1006\/bbrc.2000.4130_RF15","doi-asserted-by":"crossref","first-page":"13613","DOI":"10.1074\/jbc.274.19.13613","article-title":"Evidence for a role of a tumor necrosis factor-\u03b1 (TNF-\u03b1)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival","volume":"274","author":"Lum","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1006\/bbrc.2000.4130_RF16","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1006\/bbrc.2000.4130_RF17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0167-5699(00)01718-7","article-title":"Osteoprotegerin ligand: A regulator of immune responses and bone physiology","volume":"21","author":"Kong","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1006\/bbrc.2000.4130_RF18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: A novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1006\/bbrc.2000.4130_RF19","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev."},{"key":"10.1006\/bbrc.2000.4130_RF20","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1006\/bbrc.2000.4130_RF21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.1998.13.2.205","article-title":"Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma","volume":"13","author":"Hicok","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/bbrc.2000.4130_RF22","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jbmr.5650100203","article-title":"Development and characterization of a conditionally immortalized human fetal osteoblastic cell line","volume":"10","author":"Harris","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1006\/bbrc.2000.4130_RF23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.1998.9394","article-title":"Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines","volume":"250","author":"Hofbauer","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bbrc.2000.4130_RF24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1006\/bbrc.2000.4130_RF25","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"10.1006\/bbrc.2000.4130_RF26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/bbrc.1998.9118","article-title":"Osteoblastic differentiation is enhanced by rapamycin in rat osteoblastic-like osteosarcoma (ROS 17\/28) cells","volume":"249","author":"Ogawa","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/bbrc.2000.4130_RF27","doi-asserted-by":"crossref","first-page":"11086","DOI":"10.1073\/pnas.92.24.11086","article-title":"Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells","volume":"92","author":"Yeh","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2000.4130_RF28","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1210\/endo.141.12.7840","article-title":"The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated","volume":"141","author":"Gori","year":"2000","journal-title":"Endocrinology"},{"key":"10.1006\/bbrc.2000.4130_RF29","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.192.4.463","article-title":"Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis","volume":"192","author":"Min","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1006\/bbrc.2000.4130_RF30","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0169-6009(08)80172-9","article-title":"Effect of cyclosporine A on normal human osteoblasts in vitro","volume":"26","author":"Nacher","year":"1994","journal-title":"Bone Miner."},{"key":"10.1006\/bbrc.2000.4130_RF31","first-page":"403","article-title":"Vascular effects of cyclosporine A in vivo and in vitro","volume":"137","author":"Ferns","year":"1990","journal-title":"Am. J. Pathol."},{"key":"10.1006\/bbrc.2000.4130_RF32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007890-199509000-00002","article-title":"Atherogenic effects of cyclosporine in an experimental model of arterial autograft","volume":"60","author":"Bellon","year":"1995","journal-title":"Transplantation"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X00941305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X00941305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T08:55:56Z","timestamp":1557305756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X00941305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0006291X00941305"],"URL":"https:\/\/doi.org\/10.1006\/bbrc.2000.4130","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}